Nodular enhancement of < or = 15 HU after contrast material administration is strongly predictive of a benign lesion (Sensibility 73%, Specificity 80%, Accuracy 83%), whereas enhancement of > or = 20 HU typically indicates malignancy (Se 84%, Sp 80%, Accuracy 83%).